Cardiovascular risk, inflammation and physical activity in rheumatoid arthritis

Current Rheumatology Reviews

Volumn 8, Issue 3, 2012, Pages 180-186

  Tierney, Marie ^a   Fraser, Alexander ^b   Kennedy, Norelee ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

Atherosclerosis; Cardiovascular; Inflammation; Inflammatory markers; Physical activity; Rheumatoid arthritis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FIBRINOGEN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR;

ALCOHOL CONSUMPTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMOBILIZATION; IMMUNOMODULATION; INFLAMMATION; INSULIN RESISTANCE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SMOKING; STRESS; THROMBOEMBOLISM;

EID: 84873118298     PISSN: 15733971     EISSN: 18756360     Source Type: Journal    
DOI: 10.2174/1573212700124103971     Document Type: Article

References (63)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care Res 2008; 59(12): 1690-1697.
2. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis. Circulation 2003; 107(9): 1303-1307.
3. Del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44(12): 2737-2745.
4. Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69(2): 325-331.
5. Caspersen C, Powell E, Christenson G. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985; 100: 126-131.
6. Aadahl M, von Huth Smith L, Pisinger C, et al. Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: The Inter99 study. Prev Med 2009; 48(4): 326-331.
7. McGuire KA, Janssen I, Ross R. Ability of Physical Activity to Predict Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors. Am J Cardiol 2009; 104(11): 1522-1526.
8. Valle ED, Stranges S, Trevisan M, et al. Self-rated measures of physical activity and cardiovascular risk in a sample of Southern Italian male workers: The Olivetti Heart Study. Nutr Metab Cardiovasc Dis 2004; 14(3): 143-149.
9. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The Associations Between Physical Activity and Inflammatory Markers in High-Functioning Older Persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 2003; 51(8): 1125-1130.
10. Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol 2003; 91(3): 368-370.
11. Yates T, Davies M, Brady E, et al. Walking and inflammatory markers in individuals screened for type 2 diabetes. Prev Med 2008; 47(4): 417-421.
12. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJCS, et al. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology 2008; 47(3): 239-48.
13. McEntegart A, Capell HA, Creran D, et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 40(6): 640-644.
14. Brady SRE, de Courten B, M. RC, et al. The Role of Traditional Cardiovascular Risk Factors Among Patients with Rheumatoid Arthritis. J Rheumatol 2009; 36(1): 34-40.
15. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004; 50(11): 3444-3449.
16. Westlake SL, Colebatch AN, Baird J, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2010; 49(2): 295-307.
17. Rho YH, Oeser A, Chung CP, Milne GL, Stein CM. Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf 2009; 2(2): 34-40.
18. Jacobsson LTH, Turesson C, Gülfe A, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005; 32(7): 1213-1218.
19. Nurmohamed MT. Cardiovascular risk in rheumatoid arthritis. Autoimmunity Reviews 2009; 8(8): 663-667.
20. Tandon V, Mahajan A, Verma S. Statins and Rheumatoid arthritis. J Ind Rheumat Asso 2005; 13(2): 54-59.
21. Ambrose N, O'Connell P, Kearns G. Limiting cardiovascular risk in Irish rheumatoid arthritis patients. Ir J Med Sci 2009; 178(1): 53-55.
22. Johnson AG, Nguyen TV, Day RO. Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis. Ann Intern Med 1994; 121(4): 289-300.
23. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332(7553): 1302-1308.
24. Nurmohamed MT, van Halm VP, Dijkmans BAC. Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis. Drugs 2002; 62: 1599-1609.
25. Rozman B, Praprotnik S, Logar D, et al. Leflunomide and hypertension. Ann Rheum Dis 2002; 61(6): 567-569.
26. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994; 70(830): 863-870.
27. Souverein PC, Berard A, Van Staa TP, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004; 90(8): 859-865.
28. Wei L, MacDonald TM, Walker BR. Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease. Ann Intern Med 2004; 141(10): 764-770.
29. Marcuzzi A, Tommasini A, Crovella S, Pontillo A. Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. International Immunopharmacology 2010; 10(6): 639-642.
30. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265(3): 621-636.
31. Xing Z, Gauldie J, Cox G, et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101(2): 311-320.
32. Ablij HC, Meinders AE. C-reactive protein: history and revival. Eur J Intern Med 2002; 13(7): 412-422.
33. Sodin-Semrl S, Zigon P, Cucnik S, et al. Serum amyloid A in autoimmune thrombosis. Autoimmun Rev 2006; 6(1): 21-27.
34. Hatanaka E, Furlaneto CJ, Ribeiro FP, Souza GM, Campa A. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-[alpha]) in human neutrophils. Immunol Lett 2004; 91(1): 33-37.
35. Weisel JW. Fibrinogen and Fibrin. Adv Protein Chem 2005; 70: 247-299.
36. Núñez J, Núñez E, Sanchis J, Bodí V, Llàcer A. Prognostic Value of Leukocytosis in Acute Coronary Syndromes: The Cinderella of the Inflammatory Markers. Curr Med Chem 2006; 13(18): 2113-2118.
37. Jurado RL. Why Shouldn't We Determine the Erythrocyte Sedimentation Rate? Clin Infect Dis 2001; 33(4): 548.
38. Sox HC, Liang MH. The Erythrocyte Sedimentation Rate. Ann Intern Med 1986; 104(4): 515.
39. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther 2009; 11(2): 108.
40. Juge-Aubry CE, Somm E, Pernin A, et al. Adipose tissue is a regulated source of interleukin-10. Cytokine 2005; 29(6): 270-274.
41. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007; 66(10): 1316-1321.
42. Berrahmoune H, Lamont J, Fitzgerald P, Visvikis-Siest S. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases. Clin Chem Lab Med 2005; 43(7): 671-684.
43. Ross R. Atherosclerosis -- An Inflammatory Disease. N Engl J Med 1999; 340(2): 115-126.
44. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation 2002; 105(9): 1135-1143.
45. Cesari M, Penninx BWJH, Newman AB, et al. Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study. Circulation 2003; 108(19): 2317-2322.
46. Pai JK, Pischon T, Ma J, et al. Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women. New England Journal of Medicine 2004; 351(25): 2599-2610.
47. Rho Y, Chung C, Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Care & Research 2009; 61(11): 1580-1585.
48. Foster W, Carruthers D, Lip GYH, Blann AD. Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: Implications for cardiovascular pathophysiology. Thrombosis Research 2009; 123(4): 659-664.
49. del Rincón I, Williams K, Stern MP, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis & Rheumatism 2003; 48(7): 1833-1840.
50. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: A population-based study. Arthritis Rheum 2005; 52(3): 722-732.
51. Kasapis C, Thompson PD. The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers: A Systematic Review. J Am Coll Cardiol 2005; 45(10): 1563-1569.
52. Verdaet D, Dendale P, De Bacquer D, et al. Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease. Atherosclerosis 2004; 176(2): 303-310.
53. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. Journal of Leukocyte Biology 2005; 78(4): 819-835.
54. Woods JA, Vieira VJ, Keylock KT. Exercise, Inflammation, and Innate Immunity. Immunology and Allergy Clinics of North America 2009; 29(2): 381-393.
55. Geffken DF, Cushman M, Burke GL, et al. Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population. Am J Epidemiol 2001; 153(3): 242-250.
56. Colbert LH, Visser M, Simonsick EM, et al. Physical Activity, Exercise, and Inflammatory Markers in Older Adults: Findings from The Health, Aging and Body Composition Study. J Am Geriatr Soc 2004; 52(7): 1098-1104.
57. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study. Prev Med 2005; 40(4): 432-437.
58. Borodulin K, Laatikainen T, Salomaa V, Jousilahti P. Associations of leisure time physical activity, self-rated physical fitness, and estimated aerobic fitness with serum C-reactive protein among 3,803 adults. Atherosclerosis 2006; 185(2): 381-387.
59. Autenrieth C, Schneider A, Doring A. Association between Different Domains of Physical Activity and Markers of Inflammation. Med Sci Sports Exer 2009; 41(9): 1706-1713.
60. McDermott MM, Greenland P, Guralnik JM, et al. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease. Vascular Medicine 2004; 9(2): 107-115.
61. Dixon NC, Hurst TL, Talbot DCS, Tyrrell RM, Thompson D. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. J Appl Physiol 2009; 107(1): 63-68.
62. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil 2009; 16(2): 188-194.
63. Elkan AC, Hakansson N, Frostegard J, Hafstrom I. Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass - A cross sectional study. BMC Musculoskeletal Disorders 2011; 12.